checkpoints Flashcards
what mediates Rb hypophosphorylation?
cyclin D/cdk4/6 complex
what mediates Rb hyperphosphorylation?
cyclin E/cdk2 complex
describe the role of E2Fs in mediating cell cycle progression?
during early-mid g1 - unphosphorylated or hypophosphorylated Rb binds E2Fs + blocks its transcriptional activity
during r point - hyperphosphorylated Rb releases E2Fs from complex + E2Fs transcribe target genes mediating g1/s transition
E2F target gene = cyclin E -> E2Fs drive their own activation
how is E2F activity short lived?
as cell undergoes g1/s transition cyclin A/cdk2 complex inhibits E2Fs - targets E2Fs for degradation via ubiquitination
describe how cells progress to anaphase when chromosomes are aligned
APC/C activated
cohesin holds 2 sister chromatids together
APC/C ubiquitinates securin -> targets securin for proteosomal degradation
separase is held in a complex with securin = inactivates separase
when securin is degraded, separase = active
separase degrades cohesin so 2 sister chromatids can separate
what is MPF = maturation promoting factor also known as?
M-phase promoting factor
cyclin B/CDC2 complex
what is cell cycle arrest mediated by?
ATM
ATR
p53
tumour suppressor
transcription factor promoting expression of genes promoting growth suppression, apoptosis and DNA repair
target gene = p21cip1 = cdk inhibitor –> prevents cell cycle progression
DEFINE: anoikis
cell detachment induced apoptosis
myc-max complex
promotes proliferation
inhibits differentiation
mad-max complex
promotes differentiation
inhibits proliferation
what are the actions of the myc/max complex on the cell cycle clock?
- promotes cyclin D2/cdk4 complexes
- promotes E2F transcription factors
- promotes myc/miz1
what is the role of myc/miz1
- suppresses transcription of ckis so liberates cyclin D2/cdk4 & cyclin E/cdk2 complexes from inhibition
- promotes degradation of p27kip1
allows progression through r point
describe an experiment showing that myc activation alone is sufficient to relieve all constraints on proliferation
ectopically expressed myc as a fusion protein by attaching myc to an oestrogen receptor
no ligand? -> myc is sequestered in cytoplasm = inhibited
oestrogen or tamoxifen added? -> change in conformation of complex driving myc translocation to nucleus as a TF = active
when oestrogen or tamoxifen was added during G0 in absence of growth factors, myc was active enough to drive entry into g1 and s phase
what are some cancer cell strategies used to oppose TGFβ signalling?
- mutant Smad = inactivates smad
- mutant TGFβ receptor = inactivated
- deregulate pRb pathway by:
- mutate pRb = inactivates pRb
- very high expression levels of cyclin D1 - hypophosphorylates Rb
- downregulate INK4 proteins
- mutate CDK4 so unable to bind CKIs